Showing posts with label Omicron. Show all posts
Showing posts with label Omicron. Show all posts

Wednesday, 24 May 2023

Omicron: A Grim Reality Amidst COVID-19 | Chapter 2 | Novel Aspects on Pharmaceutical Research Vol. 2

 Since the disruption of bubonic plague Covid-19, that has killed in addition to 5.57 heap crowd general, the world has existed depressed for ancient times two and a half age. The spread of new coronavirus Omicron modifications after beginning, suspect, gamma, and accumulation of solid resumes. The virus, that was found in Botswana and South Africa in November, has spread briskly during the whole of the world in current weeks, outpacing some earlier popular coronavirus variant. When distinguished to other variations, Omicron has happened proved expected highly communicable and less approachable to vaccines. November 26, 2021, was when the omicron variant was top-secret as a variant of concern for one WHO (CDC, 2021) [1]. The aim of this study search out support a brief survey of what we then know about the Omicron bug and what more needs expected well-informed about allure various variations.

Author(s) Details:

Saima Mazhar,
Department of Periodontology, Bahria University Health Sciences, Pakistan.

Farzeen Tanwir,
Department of Periodontology, Bahria University Health Sciences, Pakistan.

Ayesha Mehwish,
Department of Anatomy, Bahria University Health Sciences, Pakistan.

Yasmeen Mahar,
Department of Anatomy, Bahria University Health Sciences, Pakistan.

Anum Baqar,
Department of Prosthodontics, Bahria University Health Sciences, Pakistan.

Maryam Faiz Quereshi,
Department of Anatomy, Western University of Health Sciences, Pomona, California, USA.

Areeba Younis,
Department of Anatomy, Bahria University Health Sciences, Pakistan.

Ariba Naveed,
Department of Anatomy, Bahria University Health Sciences, Pakistan.

Syed Wajahat Haseeb,
Department of Anatomy, Bahria University Health Sciences, Pakistan.

Mahail Khan,
Department of Anatomy, Bahria University Health Sciences, Pakistan.

Mariya Azam Khattak,
Department of Anatomy, Bahria University Health Sciences, Pakistan.

Please see the link here: https://stm.bookpi.org/NAPR-V2/article/view/10595

Tuesday, 31 January 2023

Synthesis of Novel Virus-Like Mesoporous Silica-ZnO-Ag Nanoparticles and Quercetin Synergize with NIR Laser for Omicron Mutated Covid-19 Virus Infectious Diseases Treatment| Chapter 5 | Research Advances in Microbiology and Biotechnology Vol. 2

 This work shows that novel viruslike mesopore silicazinc group of chemical elements/Ag nanoparticles (SZnOAg) synthesized and professionally composed on NIR laser irradiation accompanying quercetin to improve the removal the mutated virus as a biomedical application. A singular type of silica nanoparticles with a selfinflating tubular surface has existed successfully combined using a novel singlemicelle epitaxial growth process. The characteristics of the nanoparticles can be brought into harmony with respect to their core width, tubular length, and external diameter. Due to their biomimetic presentation, they can rapidly transform living containers into virus-like pieces, this SZnOAg nanomaterial has specific elimination effect on bacteriophage and Covid-19. Using epitaxial development, we can construct bacterium-like structures that maybe used for biomedicine applications. These nanomaterials and NIR ray of light could prepare the way to a new range of antiviral materials, due to the lowefficiency basic uptake of current nanoparticles, their requests in the biomedical field are limited. Herein, it obviously shows that novel mesoporous silica nanoparticles can be easily shown superior cellular rude answer property.

Author(s) Details:

Fadi Ibrahim Ahmed,
Chemistry Department, Al-Shujaa bin Al-Aslam School, Kuwait.

Please see the link here: https://stm.bookpi.org/RAMB-V2/article/view/9222

Sunday, 27 February 2022

Statistical Modelling and Epidemiological Assessment of COVID-19 Fatality in India | Chapter 08 | Emerging Trends in Disease and Health Research Vol. 3

 With successive waves of illnesses, the world was badly devastated by the continuous spread of alpha, beta, and delta SARS-CoV-2 VoC. On November 25, 2021, a new SARS-CoV-2 variation of concern (VoC), omicron, was reported, almost 23 months after the first case of COVID-19 was recorded and after an estimated 260 million infections and 5.2 million fatalities globally. India has reported 32 instances of Omicron variant as of December 10, 2021. As a result, in order to manage and control the present pandemic, it is critical to identify and evaluate the risk. The study highlights India's shocking and unparalleled COVID-19 mortality. Case Fatality Rate (CFR) is the most adaptive epidemiological measure for evaluating illness severity, and it is calculated using the Yoshikura technique. When the estimated CFR of 10 Indian states is compared to the general CFR calculation, Kerala is determined to have the lowest CFR of 0.40 percent, signifying the least severe sickness. In order to obtain the best-fitted model with the data, Weibull, Gamma, and Lognormal probability distributions are used to model mortality in India. The Gamma distribution is the best-fitting probability model, according to the research. The trend and forecasting pattern of mortality are studied using time-series modelling. The ARIMA model predicts an upward trend in death in the following days, and this foresight model aids administrative authorities and medical staff in making health-care service and infrastructure plans. For the foreseeable future, public health initiatives including immunisation as a preventative method will be beneficial.


Author(S) Details


K. K. Jose
Department of Biostatistics, St. Thomas College, Palai, Kerala, India and School of Mathematics & Statistics, M. G. University, Kottayam, India

Liji Anna Varghese
Department of Biostatistics, St. Thomas College, Palai, Kerala, India and Sree Mookambika Institute of Medical Sciences, Kanyakumari, Tamil Nadu, India.

Vivek S. Nair
Department of Biostatistics, St. Thomas College, Palai, Kerala, India and Eurofins Advinus, Bangalore, India.

Jilby C. Jose
Department of Biostatistics, St. Thomas College, Palai, Kerala, India and  Inductive Quotient Analytics Pvt. Ltd., Hyderabad, India.

View Book:- https://stm.bookpi.org/ETDHR-V3/article/view/5879